These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 18194267)

  • 1. Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum.
    Zhang G; Hou J; Shi J; Yu G; Lu B; Zhang X
    Immunology; 2008 Apr; 123(4):538-46. PubMed ID: 18194267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7-H3 augments the inflammatory response and is associated with human sepsis.
    Zhang G; Wang J; Kelly J; Gu G; Hou J; Zhou Y; Redmond HP; Wang JH; Zhang X
    J Immunol; 2010 Sep; 185(6):3677-84. PubMed ID: 20696859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis value of serum B7-H3 expression in non-small cell lung cancer.
    Zhang G; Xu Y; Lu X; Huang H; Zhou Y; Lu B; Zhang X
    Lung Cancer; 2009 Nov; 66(2):245-9. PubMed ID: 19269710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of B7-H3 costimulatory molecule in peripheral blood of myasthenia gravis patients].
    Jiang JA; Xue Q; Liu CP; Gao L; Zhang GB; Chen YJ; Zhang XG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):856-9. PubMed ID: 22863596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble mouse B7-H3 down-regulates dendritic cell stimulatory capacity to allogenic T cell proliferation and production of IL-2 and IFN-gamma.
    Xu J; Huang B; Xiong P; Feng W; Xu Y; Fang M; Zheng F; Gong F
    Cell Mol Immunol; 2006 Jun; 3(3):235-40. PubMed ID: 16893505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.
    Chapoval AI; Ni J; Lau JS; Wilcox RA; Flies DB; Liu D; Dong H; Sica GL; Zhu G; Tamada K; Chen L
    Nat Immunol; 2001 Mar; 2(3):269-74. PubMed ID: 11224528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of membrane B7-H3 costimulatory molecule but reduction of its soluble form in multiple sclerosis.
    Jiang J; Jiang J; Liu C; Zhang G; Gao L; Chen Y; Zhu R; Wang T; Wang F; Zhang X; Xue Q
    J Clin Immunol; 2013 Jan; 33(1):118-26. PubMed ID: 22996270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of MMP-2/B7-H3 in human osteoporosis.
    Feng P; Zhang H; Zhang Z; Dai X; Mao T; Fan Y; Xie X; Wen H; Yu P; Hu Y; Yan R
    Clin Immunol; 2016 Jan; 162():118-24. PubMed ID: 26631755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma sB7-H3 serves as an assistant diagnostic marker for hepatitis B virus-associated hepatocellular carcinoma].
    Xu W; Li F; Yu L; Liu J; He X; Fan R; Chen W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):744-7. PubMed ID: 25001942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the role of soluble B7-H3 in association with membrane B7-H3 expression in gastric adenocarcinoma.
    Huang L; Zhou Y; Sun Q; Cao L; Zhang X
    Cancer Biomark; 2022; 33(1):123-129. PubMed ID: 34459388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Establishment of a sandwich ELISA for testing serum sB7-H3 and detection of sB7-H3 levels in liver disease].
    Li SX; Zhang GB; Sun HH; Gao X; Zhang XG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):84-6. PubMed ID: 22230509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the role of B7-H3 haplotype in association with impaired B7-H3 expression and protection against type 1 diabetes in Chinese Han population.
    Ding S; Shan Y; Sun L; Li S; Jiang R; Chang X; Huang Z; Sun J; Liu C; Fang C; Zhang X
    BMC Endocr Disord; 2020 Aug; 20(1):123. PubMed ID: 32787907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and clinical significance of soluble B7-H3 in sera of patients with primary hepatocellular carcinoma].
    Wang F; Yu G; Liu T; Wang G; Yang J; Zhang G; Luan X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jun; 29(6):629-32. PubMed ID: 23746248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of soluble B7-H3 in liver immunopathogenesis during chronic HBV infection.
    Luan Y; Ju J; Luo L; Zhang Z; Wang J; Zhu DM; Cheng L; Zhang SY; Chen L; Wang FS; Wang S
    J Viral Hepat; 2012 Jan; 19(1):23-31. PubMed ID: 22187944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains.
    Steinberger P; Majdic O; Derdak SV; Pfistershammer K; Kirchberger S; Klauser C; Zlabinger G; Pickl WF; Stöckl J; Knapp W
    J Immunol; 2004 Feb; 172(4):2352-9. PubMed ID: 14764704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Significance of B7-H3 Expression During the Progression of Hepatitis B Virus Infection.
    Gao F; Xu JC; Zhu L; Chen H; Zhu XY; You XR; Li SX; Zhu CL; Yang C; Zhu CW; Xu P
    Viral Immunol; 2018 Dec; 31(10):668-675. PubMed ID: 30481143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble B7-H1: differences in production between dendritic cells and T cells.
    Frigola X; Inman BA; Krco CJ; Liu X; Harrington SM; Bulur PA; Dietz AB; Dong H; Kwon ED
    Immunol Lett; 2012 Feb; 142(1-2):78-82. PubMed ID: 22138406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a soluble B7-H3 (sB7-H3) spliced from the intron and analysis of sB7-H3 in the sera of patients with hepatocellular carcinoma.
    Chen W; Liu P; Wang Y; Nie W; Li Z; Xu W; Li F; Zhou Z; Zhao M; Liu H
    PLoS One; 2013; 8(10):e76965. PubMed ID: 24194851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum soluble B7-H3 is a prognostic marker for patients with non-muscle-invasive bladder cancer.
    Azuma T; Sato Y; Ohno T; Azuma M; Kume H
    PLoS One; 2020; 15(12):e0243379. PubMed ID: 33306717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.